MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer.
Saved in:
| Title: | MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer. |
|---|---|
| Authors: | German B, Singh JN, Fonseca MA, Burkhart DL, Sheahan A, Bergom H, Morel KL, Beltran H, Hwang JH, Lawrenson K, Ellis L |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 02. Date of Electronic Publication: 2024 Feb 02. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38352340 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22German+B%22">German B</searchLink><br /><searchLink fieldCode="AU" term="%22Singh+JN%22">Singh JN</searchLink><br /><searchLink fieldCode="AU" term="%22Fonseca+MA%22">Fonseca MA</searchLink><br /><searchLink fieldCode="AU" term="%22Burkhart+DL%22">Burkhart DL</searchLink><br /><searchLink fieldCode="AU" term="%22Sheahan+A%22">Sheahan A</searchLink><br /><searchLink fieldCode="AU" term="%22Bergom+H%22">Bergom H</searchLink><br /><searchLink fieldCode="AU" term="%22Morel+KL%22">Morel KL</searchLink><br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink><br /><searchLink fieldCode="AU" term="%22Hwang+JH%22">Hwang JH</searchLink><br /><searchLink fieldCode="AU" term="%22Lawrenson+K%22">Lawrenson K</searchLink><br /><searchLink fieldCode="AU" term="%22Ellis+L%22">Ellis L</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2024 Feb 02. <i>Date of Electronic Publication: </i>2024 Feb 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Preprint; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38352340 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2024.01.31.578216 Languages: – Code: eng Text: English Titles: – TitleFull: MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: German B – PersonEntity: Name: NameFull: Singh JN – PersonEntity: Name: NameFull: Fonseca MA – PersonEntity: Name: NameFull: Burkhart DL – PersonEntity: Name: NameFull: Sheahan A – PersonEntity: Name: NameFull: Bergom H – PersonEntity: Name: NameFull: Morel KL – PersonEntity: Name: NameFull: Beltran H – PersonEntity: Name: NameFull: Hwang JH – PersonEntity: Name: NameFull: Lawrenson K – PersonEntity: Name: NameFull: Ellis L IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 02 Text: 2024 Feb 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |